MarketScreener Strategies GlaxoSmithKline plc Liquidnet

Stocks

Delayed Liquidnet			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

02/10	Major drugmakers turn to China for licensing deals	RE
01/10	GSK plc : JP Morgan reiterates its Sell rating	ZD

	GSK plc: Priced for the storm, being built for thereafter	16 September 2026 at 03:09 am AEST
	GSK announces positive data from two clinical trials	14 September 2026 at 11:41 pm AEST
	A No to BMS can open doors for a Yes to GSK	12 August 2026 at 10:55 pm AEST
	Goldman Sachs still cautious about GSK	30 July 2026 at 05:07 pm AEST
	GSK plc: Another beat; we appreciate the new CEO's aggressive intent	29 July 2026 at 04:23 am AEST
	GSK plc: A beat isn't enough; markets expected an outlook upgrade	01 April 2026 at 12:57 am AEST
	GSK plc: Can bet on GSK’s gradually brightening future	11 March 2026 at 08:47 pm AEDT
	GSK plc: Eventually getting into its stride	06 February 2026 at 01:55 am AEDT
	GSK: shareholders urge company to step up reinvention	20 January 2026 at 09:20 pm AEDT
	GSK PLC outlook improves amid merger speculation	30 December 2025 at 05:20 pm AEDT
	MRNA rivals call truce as BioNTech prepares CureVac takeover	08 August 2025 at 06:30 pm AEST
	GSK plc : Back on track	03 May 2024 at 07:16 pm AEST
	GSK: UBS reiterates its recommendation on the share	02 May 2024 at 08:33 pm AEST